Tuesday, 24 September 2024 at the European Health Forum Gastein
“A European Semester on Health?” This pivotal question set the tone for a session organised by Cancer Patient Europe (CPE) and the Central European Cooperative Oncology Group (CECOG), with support from MSD at the 2024 edition of the European Health Forum Gastein (EHFG). The session on “Piloting Europe’s Beating Cancer Plan to Address Inequalities” explored how the European Semester could be leveraged to address persisting health inequalities across Europe disparities, ensuring that health, particularly remains at the forefront of EU policy and decision-making.
Stakeholders from EU institutions, civil society, and both the public and private sectors gathered in Gastein, Austria, and online, to explore how the European Semester, could become a catalyst for social convergence and improved healthcare, particularly in underprivileged areas of Europe. The session highlighted how cancer indicators could be used to pilot the inclusion of health within the European Semester.
Understanding Cancer Inequalities in Europe
One of the central themes of the session was the alarming disparities in cancer care across Europe. Christoph Zielinski, President of CECOG, emphasised the reality of geographic discrimination in cancer treatment. Zielinski called for the rational reimbursement of cancer care and urged policymakers to make survival a priority across all EU member states.
Leveraging the European Semester for Health
The European Semester, a governance tool designed to align member state policies with the European Commission’s priorities, was presented as a powerful mechanism to reduce health inequalities. Silvia Ganzerla, Policy Manager at EuroHealthNet, explained how the Semester could drive health equity by ensuring that national policies align with broader EU objectives. “The European Semester is not easy to understand, but it’s incredibly powerful,” – She noted.
The political dimension
Vytenis Andriukaitis, Member of the European Parliament and former European Commissioner for Health and Food Safety emphasised that health must remain a priority on the EU political agenda to address the persistent healthcare disparities, while also pointing out that by keeping cancer at the forefront, the EU can ensure that best practices are shared, and political accountability is strengthened both in Brussels and in Member States.
As the implementation of the EBCP progresses, he emphasized that keeping cancer at the forefront of EU policymaking will promote the sharing of best practices and reinforce political accountability both in Brussels and across Member States.
Andriukaitis also expressed his strong support for the Call to Action on establishing a European Semester for Health, encouraging other MEPs to sign the manifesto launched by CPE and CECOG earlier this year and to sustain the momentum around cancer.
The idea of creating an “EU Semester on Health,” with cancer as a pilot, was unanimously echoed throughout the first part of the session, but one question kept coming up:
Why Cancer?
Cancer is now one of the leading causes of mortality in Europe, overtaking many other diseases. Christoph Zielinski emphasised that cancer has reached an epidemic dimension, accounting for a significant and growing portion of deaths across the continent. Cancer care requires interdisciplinary collaboration, making it a prime area to address inequalities in healthcare access.
Focusing on cancer can act as a blueprint for tackling other chronic diseases. Cancer care covers the entire spectrum of healthcare needs, from prevention, diagnosis, surgery, and treatment, to palliative care, offering a comprehensive framework that could be applied to other health areas.
Cancer also serves as an ideal case study because it highlights many of the inequities in access to healthcare. As Antonella Cardone succinctly put it, “Inequalities in access to cancer care are not just about quality of life; they are a matter of surviving a diagnosis of cancer or dying.”
By targeting cancer, policymakers can address these systemic health disparities, paving the way for better health outcomes in therapeutic areas.
What are the key Challenges?
Despite the promises of the European Semester, panellists acknowledged the obstacles in translating EU policies into actionable measures at the country level. Marilys Corbex, Senior Technical Officer at the WHO Regional Office for Europe, identified commercial interests as one of the major barriers to implementing cost-effective cancer prevention policies.
Why Engaging Stakeholders is important?
The second part of the session focused on how to make a European Semester on Health a reality through an interactive workshop with participants. Building on these exchanges, Alina Comanescu, Founder of the Community Health Association Romania, stressed the importance of including patient voices in the process.
“Patients should be involved in each step of the EU Semester, as they understand the barriers firsthand, from screening to diagnosis, to accessing treatment, and even palliative care. That’s why we must advocate for equal access to quality healthcare,” she explained.
The inclusion of patients in policy-making processes, particularly in setting key performance indicators (KPIs) and monitoring implementation, was seen as critical to the success of a European Semester on Health. This approach ensures that real-world challenges are addressed and that policies are tailored to meet the needs of those directly affected by cancer, including here, also caregivers who are often forgotten.
Prioritising Key Indicators for the EU Cancer Dashboard
Alexander Roediger, Associate Vice President, Global Oncology Policy at MSD, emphasised several crucial indicators for assessing the effectiveness of cancer care. Key performance indicators (KPIs) such as survival incidence and cancer prevalence provide insights into the efficacy of prevention programs. Additionally, the five-year survival rate of cancer patients highlights disparities and access to care, while the number of patients who remain in the workforce post-diagnosis reflects the speed and quality of diagnosis and treatment. These metrics underscore the importance of evaluating cancer care’s impact on both patient outcomes and broader societal implications.
How can we ensure a successful and sustainable implementation of the European Semester on Health?
Josephine Mosset, representing the Young Forum Gastein, and Policy Officer at CPE, outlined the success factors necessary for the implementation of a European Semester on Health.
Institutional coordination, through the inclusion of DG SANTE in the piloting of the Semester and policy conditionality, where health is considered on the same level as other policies, is essential for its sustainability. She emphasised that synergies with existing health initiatives, such as Europe’s Beating Cancer Plan (EBCP), should be leveraged to streamline efforts.
The Path Forward: A Call to Action
As the session concluded, Antonella Cardone summarised the main takeaways.
“The inclusion of health in the European Semester is timely due to the current political moment, with a new Commission and Parliament in place. We believe starting with cancer as a pilot will serve as a blueprint for other disease areas and health policy more broadly.” – she stated.
In February 2024, CPE and CECOG launched a joint manifesto advocating for the inclusion of health and cancer in the European Semester. With support from several MEPs and organisations across the patient, academic, and health sectors, this initiative aims to push health to the forefront of EU policy.
Piloting a European Semester on Cancer will bring us closer to ensuring that “Where people live should not determine if they live.”.
We count on the support from stakeholders to make this vision a reality, ensuring that health remains a priority for Europe and that no patient is left behind.




